Preparing for stricter standards on substances of human origin
European Pharmaceutical Review
JULY 20, 2023
In addition to hospitals and blood transfusion centres, pharmaceutical, device and other companies involved with blood products and cell- and gene-therapy products are advised to closely monitor developments surrounding the proposed regulation. Strict requirements apply, especially with regard to traceability and coding.
Let's personalize your content